由于COVID-19引发了前所未有的公共卫生危机,这是我们对新发行的期刊的第一篇贡献,生物标志物科学与技术进展,突然转向关注当前的大流行。随着全球新增COVID-19病例和死亡人数继续稳步上升,医疗保健提供者的共同目标,科学家,世界各地的政府官员一直在确定检测新型冠状病毒的最佳方法,命名为SARS-CoV-2,并治疗病毒感染-COVID-19。准确的检测,及时诊断,有效治疗,和未来的预防是COVID-19管理的关键,可以帮助遏制病毒传播。传统上,生物标志物在疾病病因的早期检测中起着关键作用,诊断,治疗和预后。为了协助无数正在进行的调查和创新,我们开发了这篇最新的文章来概述已知的和新兴的用于SARS-CoV-2检测的生物标志物,COVID-19诊断,治疗和预后,以及正在进行的工作,以确定和开发更多的新药物和疫苗的生物标志物。此外,社会心理压力的生物标志物,对新虚拟药物筛选的高科技追求,并描述了数字应用。
Due to the unprecedented public health crisis caused by COVID-19, our first contribution to the newly launching journal, Advances in Biomarker Sciences and Technology, has abruptly diverted to focus on the current pandemic. As the number of new COVID-19 cases and deaths continue to rise steadily around the world, the common goal of healthcare providers, scientists, and government officials worldwide has been to identify the best way to detect the novel coronavirus, named SARS-CoV-2, and to treat the viral infection - COVID-19. Accurate detection, timely diagnosis, effective treatment, and future prevention are the vital keys to management of COVID-19, and can help curb the viral spread. Traditionally, biomarkers play a pivotal role in the early detection of disease etiology, diagnosis, treatment and prognosis. To assist myriad ongoing investigations and innovations, we developed this current article to overview known and emerging biomarkers for SARS-CoV-2 detection, COVID-19 diagnostics, treatment and prognosis, and ongoing work to identify and develop more biomarkers for new drugs and vaccines. Moreover, biomarkers of socio-psychological stress, the high-technology quest for new virtual drug screening, and digital applications are described.